These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 5505392

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dihydrotachysterol (DHT) and supplemental calcium therapy in dialysis patients.
    Kliger AS, Yap P, Jensen P, Finkelstein FO.
    Proc Clin Dial Transplant Forum; ; 6():184-90. PubMed ID: 1029884
    [No Abstract] [Full Text] [Related]

  • 4. Dihydrotachysterol and calcitriol in long-term dialyzed patients with renal bone disease.
    Wilczek H, Stĕpán J, Pacovský V.
    Acta Univ Carol Med (Praha); 1986; 32(5-6):339-43. PubMed ID: 3439519
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D, Kraft D, Schaefer K, Krempien B.
    MMW Munch Med Wochenschr; 1974 Sep 13; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract] [Full Text] [Related]

  • 6. Indications for parathyroidectomy in advanced renal disease.
    Buck BA, Robertson RD.
    Surg Gynecol Obstet; 1971 Aug 13; 133(2):218-24. PubMed ID: 4935588
    [No Abstract] [Full Text] [Related]

  • 7. The effect of hemodialysis, vitamin D, and renal homotransplantation on the calcium malabsorption of chronic renal failure.
    Messner RP, Smith HT, Shapiro FL, Gregory DH.
    J Lab Clin Med; 1969 Sep 13; 74(3):472-81. PubMed ID: 4896821
    [No Abstract] [Full Text] [Related]

  • 8. Disorders of calcium and bone metabolism in chronic renal failure.
    Avioli LV.
    Mod Treat; 1970 May 13; 7(3):675-85. PubMed ID: 4920810
    [No Abstract] [Full Text] [Related]

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 13; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 10. Arrest of hyperparathyroid bone disease with dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M, Chatterjee G, Cohen GF.
    Ann Intern Med; 1970 Aug 13; 73(2):225-33. PubMed ID: 5311514
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005 Aug 13; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 12. Paricalcitol, a new agent for the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis.
    Goldenberg MM.
    Clin Ther; 1999 Mar 13; 21(3):432-41. PubMed ID: 10321413
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of alfacalcidol and parathyroidectomy with vitamin D in hyperparathyroid renal bone disease.
    Cundy T, Kanis JA, Earnshaw M, Woods CG.
    Q J Med; 1986 Jul 13; 60(231):659-70. PubMed ID: 3763817
    [Abstract] [Full Text] [Related]

  • 14. Azotemic osteodystrophy - indications for intervention.
    Ritz E.
    Prog Biochem Pharmacol; 1980 Jul 13; 17():251-8. PubMed ID: 7208504
    [Abstract] [Full Text] [Related]

  • 15. Long-term low-dose calcitriol treatment in predialysis chronic renal failure: can it prevent hyperparathyroid bone disease?
    Nordal KP, Dahl E, Halse J, Attramadal A, Flatmark A.
    Nephrol Dial Transplant; 1995 Jul 13; 10(2):203-6. PubMed ID: 7753453
    [Abstract] [Full Text] [Related]

  • 16. Parathyroidectomy in the treatment of renal osteodystrophy. Calcium dynamic studies.
    Hubay CA, Gonzalez-Barcena D, Klein L, Frankel V, Eckel RE, Pearson OH.
    Arch Surg; 1970 Aug 13; 101(2):181-92. PubMed ID: 5451199
    [No Abstract] [Full Text] [Related]

  • 17. Dihydrotachysterol and vitamin D resistance in renal failure.
    Sagar S, Estrada RL, Kaye M.
    Arch Intern Med; 1972 Nov 13; 130(5):768-9. PubMed ID: 4538857
    [No Abstract] [Full Text] [Related]

  • 18. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N, Cooney P, Kerr PG.
    Hemodial Int; 2006 Oct 13; 10(4):326-37. PubMed ID: 17014507
    [Abstract] [Full Text] [Related]

  • 19. Defective calcium absorption in the proximal small intestine in chronic renal failure: effect of dihydrotachysterol.
    Coen G, Segni MD, Stirati G, Cinotti GA.
    J Urol Nephrol (Paris); 1976 Oct 13; 82(4-5):339-43. PubMed ID: 940179
    [Abstract] [Full Text] [Related]

  • 20. [Iatrogenic kidney-calculi formation and kidney failure due to long-term treatment with calcinosis factors (dihydrotachysterol, vitamin D)].
    Gebhardt K.
    Z Arztl Fortbild (Jena); 1977 May 01; 71(9):447-9. PubMed ID: 878519
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.